<DOC>
	<DOCNO>NCT03002974</DOCNO>
	<brief_summary>The purpose study evaluate anakinra relief pain patient acute gout take non-steroidal anti-inflammatory drug ( NSAIDs ) colchicine . The patient divide different treatment group compare anakinra available drug triamcinolone .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Anakinra Treatment Acute Gouty Arthritis</brief_title>
	<detailed_description>Patients randomize treatment first gout flare study . The first treatment period follow extension period patient receive treatment subsequent flare within 52 week randomization . Each new flare treat initiate new series study visit assessment accord specified schedule event . Only patient experience new flare Day 15 late flare start new treatment period . The comparison primary interest anakinra ( 100 mg 200 mg combine ) 40 mg triamcinolone , secondary objective 2 different dos anakinra evaluate well assessment subsequent flare .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Gouty</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Signed Informed consent Patient meeting American College Rheumatology/ European League Against Rheumatism ( ACR/EULAR ) 2015 gout classification criterion History ≥3 selfreported flare gouty arthritis within 12 month Current ongoing flare gouty arthritis characterize pain intensity Currently tender swell joint Onset current flare within 4 day Intolerant , unresponsive , contraindicated appropriate treatment NSAIDs colchicine ( treatment option ) Body mass index ( BMI ) less 40 kg/m2 . If uratelowering therapy , stable dose regimen Women childbearing potential willing use adequate contraception Inclusion criterion treatment subsequent flare ( ) Current flare gouty arthritis characterize pain intensity Currently tender swell joint Women childbearing potential willing use adequate contraception Use specify pain relief medication biologics ( include glucocorticoid , narcotic , paracetamol/acetaminophen , NSAIDs , colchicine , ILblockers tumor necrosis factor inhibitor ) within specify period prior randomization Contraindication triamcinolone Polyarticular gouty arthritis involve 4 joint Rheumatoid arthritis , evidence/suspicion infectious/septic arthritis , acute inflammatory arthritis History malignancy within past 5 year . Exceptions basal cell skin cancer , carcinomainsitu cervix lowrisk prostate cancer curative therapy . Known hypersensitivity Escherichia coliderived protein , Kineret® ( anakinra ) , Kenalog® ( triamcinolone acetonide ) component product . Known presence suspicion active recurrent bacterial , fungal viral infection , include tuberculosis , HIV infection hepatitis B C infection Presence severe renal function impairment chronic kidney disease ( CKD ) stag 4 5 Presence neutropenia Uncontrolled clinically significant hematologic , pulmonary , endocrine , metabolic , gastrointestinal , central nervous system hepatic disease History myocardial infarction , unstable angina , cerebrovascular event , coronary artery bypass grafting , New York Heart Association ( NYHA ) class III IV heart failure within previous 3 month Patients undergone major surgery within 2 week , unhealed operation wound/s Presence medical psychological condition laboratory result opinion investigator might create risk patient study . Earlier current treatment anakinra Pregnant lactate woman History &gt; 12 flare overall 6 month prior randomization Exclusion criterion treatment subsequent flare ( ) : Known presence suspicion active recurrent bacterial , fungal viral infection , include tuberculosis , HIV infection hepatitis B C infection . Presence severe renal function impairment CKD stag 4 5 Presence neutropenia History myocardial infarction , unstable angina , cerebrovascular event , coronary artery bypass grafting , NYHA class III IV heart failure within previous 3 month Patients undergone major surgery within 2 week unhealed operation wound/s . Pregnant lactating woman . Presence condition laboratory result opinion investigator make patient appropriate treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Gout</keyword>
	<keyword>Interleukin 1 receptor antagonist</keyword>
	<keyword>IL-1 receptor antagonist</keyword>
</DOC>